Delivery Order SPE2DB22D9319-SPE2DB24FK2MY
Award Date 5/17/24
Potential Completion Date 6/10/24
Potential Value $4.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $4,288.14 and covers the delivery of 68 mg Nexplanon contraceptive implants. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a wide range...
- This is a $3,698.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for 4,558,244,879 units of Nexplanon 68 mg implants, a contraceptive product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA, which allows the DLA to issue firm...
- This is a $5,717.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the procurement of 4,564,764,375 units of the contraceptive implant Nexplanon 68 mg, with a period of performance through June 14, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,471.55 order is for 4,568 units of the Nexplanon 68 mg contraceptive implant. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which allows the agency to issue firm fixed-price delivery orders for a...
- The Defense Logistics Agency (DLA) has awarded a $4,288.14 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the provision of 4,566,708,636 units of the contraceptive implant Nexplanon 68 mg. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. valued at $499,999,999, which enables the DLA to issue firm...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,573.45, is for the supply of Nexplanon 68 mg contraceptive implants. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue firm...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $4,288.14, is for the delivery of 68 mg NEXPLANON contraceptive implants. The contract has an ultimate completion date of July 1, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 contract is for the delivery of Nexplanon 68 mg implants, a contraceptive product, to support the recurring medical supply needs of military health facilities. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $28,587.60 firm fixed-price contract is for the supply of Nexplanon 68 mg implants, which are a contraceptive product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,288.14, is for the delivery of Nexplanon 68 mg implants, a contraceptive product. This order is part of a larger, single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
- SPE2DB22D9319Indefinite Delivery Contract
- SPE2DB22D9319-SPE2DB24FK2MYDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 order is for the delivery of 68 mg Nexplanon contraceptive implants. The award is associated with a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This IDC, under the DLA's SPE2DB program, does not have a set-aside designation.
Generated 8/16/24, 9:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 5/17/24 |